SNRPGP17

Across TCGA pan-cancer cohorts, SNRPGP17 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated SNRPGP17 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher SNRPGP17 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SNRPGP17 expression acts as an unfavorable survival marker, although some lineages such as MESO and BLCA show a favorable association.

KIRC, ACC, and STAD are the cancer types where SNRPGP17 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	IV	0.325	0.551	.005	96	view →
ACC	DFS	Tertile	IV	0.048	0.435	<.001	60	view →
STAD	OS	Quartile	All	0.329	0.607	.004	27	view →
MESO	OS	Tertile	All	0.781	0.355	.031	21	view →
BLCA	OS	Tertile	All	0.721	0.575	.023	20	view →
THYM	DFS	Tertile	All	0.798	0.942	.006	18	view →
PAAD	DFS	Tertile	All	0.606	0.326	.023	12	view →
SARC	OS	Tertile	All	0.245	0.612	.012	12	view →
ESCA	DFS	Tertile	IV	0.231	0.704	.024	12	view →
BRCA	OS	Tertile	All	0.951	0.914	.026	10	view →
SKCM	DFS	Tertile	III,IV	0.465	0.190	.015	9	view →
LIHC	DFS	Tertile	III,IV	0.126	0.445	.003	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

SNRPGP17–KIRC (DFS)

Open the KIRC breakdown →